Overview
Paul Martin is an Oncologist practicing medicine in Seattle, Washington.
Dr. Martin is highly rated in 3 conditions, according to our data. His clinical expertise encompasses Acute Myeloblastic Leukemia without Maturation, Acute Myeloid Leukemia (AML), Chronic Graft Versus Host Disease (cGvHD), and Acute Myeloblastic Leukemia with Maturation.
Specialties
Licenses
Languages Spoken
Gender
Insurance
Accepted insurance can change. Please verify directly with the provider.
Accepted insurance plans:
- EPO
- HMO
- POS
- PPO
- HMO
- INDEMNITY
- POS
- PPO
Locations
1959 NE Pacific St, Seattle, WA 98195
Rachel Loschiavo PA-C
Ajay Gopal is an Oncologist practicing medicine in Seattle, Washington. Dr. Gopal is highly rated in 22 conditions, according to our data. His clinical expertise encompasses Follicular Lymphoma, Non-Hodgkin Lymphoma, Hodgkin Lymphoma, and Classical Hodgkin Lymphoma.
Swedish Cardiovascular RSRCH
John Pagel is an Oncologist practicing medicine in Seattle, Washington. Dr. Pagel is highly rated in 19 conditions, according to our data. His clinical expertise encompasses Chronic B-Cell Leukemia (CBCL), Chronic Lymphocytic Leukemia (CLL), Follicular Lymphoma, Bone Marrow Transplant, and Bone Marrow Aspiration.
Gme Office University Of Washington
Bart Scott is an Oncologist practicing medicine in Seattle, Washington. Dr. Scott is highly rated in 13 conditions, according to our data. His clinical expertise encompasses Myelodysplastic Syndrome (MDS), Acute Myeloid Leukemia (AML), Chronic Myelomonocytic Leukemia (CMML), Leukemia, and Bone Marrow Aspiration.
Frequently Asked Questions about Dr. Paul Martin
How do I make an appointment with Dr. Paul Martin?
You can book an appointment with Dr. Paul Martin by calling their office at 206-288-1000. MediFind provides direct contact information so you can schedule visits, second opinions, or consultations without navigating third-party calendars.
Is Dr. Paul Martin a top-rated expert for Acute Myeloblastic Leukemia without Maturation?
MediFind is an objective health platform that identifies experts based on real-world data. Dr. Paul Martin is classified as an Advanced expert for Acute Myeloblastic Leukemia without Maturation, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.
What conditions does Dr. Paul Martin specialize in?
While Dr. Paul Martin is a Oncology, they have specific expertise in Acute Myeloblastic Leukemia without Maturation, Acute Myeloid Leukemia (AML), and Chronic Graft Versus Host Disease (cGvHD). MediFind analyzes a doctor's articles and referral patterns to identify their specific areas of focus within Oncology.
Does Dr. Paul Martin accept my insurance?
Dr. Paul Martin accepts most major insurance plans, including Aetna and Humana. We recommend calling the office directly at 206-288-1000 to verify that your specific plan is currently accepted before your visit.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Advanced
- Acute Myeloblastic Leukemia without Maturation
- Acute Myeloid Leukemia (AML)Dr. Martin isAdvanced. Learn about Acute Myeloid Leukemia (AML).
- Chronic Graft Versus Host Disease (cGvHD)
- Experienced
- Acute Lymphoblastic Leukemia (ALL)Dr. Martin isExperienced. Learn about Acute Lymphoblastic Leukemia (ALL).
- Acute Myeloblastic Leukemia with Maturation
- Childhood Acute Myeloid LeukemiaDr. Martin isExperienced. Learn about Childhood Acute Myeloid Leukemia.
- Chronic Myelomonocytic Leukemia (CMML)Dr. Martin isExperienced. Learn about Chronic Myelomonocytic Leukemia (CMML).
- Myelodysplastic Syndrome (MDS)Dr. Martin isExperienced. Learn about Myelodysplastic Syndrome (MDS).
- MyelofibrosisDr. Martin isExperienced. Learn about Myelofibrosis.